Sign in
Taking people in United StatesNo phase

Following unaffected relatives of people with inflammatory bowel disease over time

Follows close relatives of people with Crohn's or colitis who lack the disease.

Key facts

Who runs it
Massachusetts General Hospital
Where
Boston, United StatesSee the site
Trial code
Registry title
Family Members at INcreased-risk for Developing Inflammatory Bowel Disease
Status
Recruiting
People taking part
50 people, planned
Started
18 Dec 2024
Expected to end
Dec 2034
Type of study
Observational
Record updated
7 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 14 or older who do not have IBD but have at least one close blood relative (parent, brother, sister or child) with IBD. They are followed over time.

Age
14 years or older
Sex
All sexes can join
Disease stage
Must not have IBD or clinical signs or symptoms of IBD.

Main reasons for not taking part

  • Already diagnosed with ulcerative colitis, Crohn's disease or IBD-unclassified
  • Signs or symptoms of IBD found at the pre-screening interview
  • Cannot give informed consent
  • Cannot complete all study visits and procedures
  • Cannot understand and complete the study questionnaires

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Ability to give informed consent
  • Ability to complete all study visits and study-related procedures
  • Ability to understand and complete study questionnaires
  • Must have at least one first-degree relative with inflammatory bowel disease (Crohn's disease, ulcerative colitis, or IBD-unclassified)
  • Age ≥ 14

Who cannot take part

  • Individuals with existing diagnoses of inflammatory bowel disease (ulcerative colitis, Crohn's disease, or IBD-unclassified)
  • Evidence of clinical signs or symptoms of IBD, which will be identified on pre-screening interview with the study coordinator

Where in United States

  • Massachusetts General HospitalBoston, United StatesContact: Emily W Lopes, MD, MPHTaking people

About the trial

What the trial wants to find out

First-degree relatives of people with inflammatory bowel disease ("IBD," including Crohn's disease and ulcerative colitis) have an increased risk for developing IBD themselves. This study will follow unaffected first-degree relatives (who do not have IBD) over time to understand if their behaviors, diet, and biomarkers for IBD can help predict who gets IBD and if IBD can be prevented in these high-risk individuals. Participants will be asked once per year to complete a questionnaire and have their blood, stool, and urine collected. The anticipated length of the study (registry) is approximately 10 years or longer. Parts of this study, such as the questionnaires and stool and urine collection, may be done from home, while other parts, such as the blood draw, will need to be done from Massachusetts General Hospital.

The group in the trial

  • Individuals who have a parent, sibling, or child with IBD but who do not have IBD themselves

    Adult and adolescent (greater than 14 years of age) first-degree relatives (parents, siblings, or children) of patients with inflammatory bowel disease (including Crohn's disease, ulcerative colitis, or inflammatory bowel disease-unclassified/indeterminate colitis) but who do not have inflammatory bowel disease themselves.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Family Members at INcreased-risk for Developing Inflammatory Bowel Disease (FIND-IBD)
Plain-language title
Following unaffected relatives of people with inflammatory bowel disease over timeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
7 October 2026